SCHEMBL21033067

SCHEMBL21033067

COc1ccc2c(c1OC)C(=O)N(c1cccc(C)c1)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 1.00
RAB9A P51151 8/20 1.00
SMN1; SMN2 Q16637 5/20 1.00
TP53 P04637 3/20 1.00
TSHR P16473 2/20 1.00
GAA P10253 1/20 1.00
MAPT P10636 1/20 0.71
NFKB1 P19838 1/20 0.71
NFKB2 Q00653 1/20 0.71
RELA Q04206 1/20 0.71
POLB P06746 3/20 0.67
KMT2A Q03164 2/20 0.65
ALDH1A1 P00352 5/20 0.59
KDM4E B2RXH2 3/20 0.58
HPGD P15428 3/20 0.58
HSD17B10 Q99714 3/20 0.58
MEN1 O00255 1/20 0.57
PARP1 P09874 1/20 0.55
ATM Q13315 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4726022 0.86 NPC1 (0.76) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL13171356 0.84 RAB9A (1.00) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL4727877 0.78 NPC1 (0.78) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL10085805 0.76 RAB9A (0.74) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL13952300 0.73 RAB9A (0.62) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL4727985 0.72 KMT2A (1.00) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL1806107 0.72 RAB9A (0.61) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL22340597 0.72 NPC1 (0.69) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL835316 0.72 PARP1 (0.79) NPC1RAB9ASMN1; SMN2TP53TSHR
SCHEMBL13952121 0.71 RAB9A (0.59) NPC1RAB9ASMN1; SMN2TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104201-A1 SMALL MOLECULE AGONISTS AND ANTAGONISTS OF NR2F6 ACTIVITY IN NON-HUMANS Zander Therapeutics, Inc. (US) 2019-05-31 WO disclosed
WO-2019104199-A1 SMALL MOLECULE AGONISTS AND ANTAGONISTS OF NR2F6 ACTIVITY REGEN BIOPHARMA INC. (US) 2019-05-31 WO disclosed